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ABSTRACT
Higher eukaryotes encode various Y-family DNA
polymerases to perform global DNA lesion bypass.
To provide complete mutation spectra for abasic
lesion bypass, we employed short oligonucleotide
sequencing assays to determine the sequences of
abasic lesion bypass products synthesized by
human Y-family DNA polymerases eta (hPolg), iota
(hPoli) and kappa (hPoli). The fourth human
Y-family DNA polymerase, Rev1, failed to generate
full-length lesion bypass products after 3h. The
results indicate that hPoli generates mutations
with a frequency from 10 to 80% during each nu-
cleotide incorporation event. In contrast, hPolg is
the least error prone, generating the fewest muta-
tions in the vicinity of the abasic lesion and inserting
dAMP with a frequency of 67% opposite the abasic
site. While the error frequency of hPoli is intermedi-
ate to those of hPolg and hPoli, hPoli has the
highest potential to create frameshift mutations
opposite the abasic site. Moreover, the time
(t50
bypass) required to bypass 50% of the abasic
lesions encountered by hPolg, hPoli and hPoli was
4.6, 112 and 1823s, respectively. These t50
bypass
values indicate that, among the enzymes, hPolg
has the highest abasic lesion bypass efficiency.
Together, our data suggest that hPolg is best
suited to perform abasic lesion bypass in vivo.
INTRODUCTION
DNA polymerases are grouped into the A-, B-, C-, D-, X-
and Y-families. The Y-family DNA polymerases function
primarily in the bypass of replication-stalling DNA
lesions, a process which can ultimately decrease the possi-
bility of invoking DNA damage-induced apoptosis. In
humans, 4 of the 16 identiﬁed DNA polymerases are in
the Y-family: DNA polymerases eta (hPolZ), iota (hPoli),
kappa (hPolk) and Rev1 (hRev1). In numerous biochem-
ical studies (1–3), these enzymes are capable of both
error-free and error-prone lesion bypass, depending on
the speciﬁc lesion. In vivo, hPolZ is responsible for the
error-free bypass of cis-syn thymine–thymine (TT)
dimers (4,5). Moreover, the mutational inactivation of
hPolZ leads to xeroderma pigmentosum variant (XPV)
that predisposes individuals to an increased incidence of
sunlight-induced skin cancer (5). hPolZ also has been
shown biochemically to bypass lesions including abasic
sites (AP) (6), 7,8-dihydro-8-oxoguanine (8-oxoG) (7),
(+)-trans-anti-benzo[a]pyrene-N
2-dG [(+)BPDE-dG] (6),
1,N
6-ethenodeoxyadenosine (8), O
6-methylguanine
(9), N-2-acetylaminoﬂuorene-dG (AAF-dG) (10) and
cisplatin-dGpG intrastrand adducts (10). Interestingly,
Poli has been shown to incorporate incorrect dGMP
opposite a template base dT more efﬁciently than canon-
ical dAMP (11,12). In vitro, hPoli has been shown to
traverse AP sites (12–14), 8-oxoG (14), AAF-dG (14),
cis-syn TT dimers (13) and (6-4) TT photoproducts
(14,15). Polk, which is a member of the DinB subfamily
and a close relative of Y-family member Sulfolobus
solfataricus DNA Polymerase IV (Dpo4), can efﬁciently
elongate mispaired primer termini (16). In addition,
hPolk has been shown to bypass AP sites, 8-oxoG,
AAF-dG and (+)BPDE-dG (17). Rev1, which is the only
Y-family DNA polymerase to contain a BRCT domain, is
classiﬁed as a dCMP transferase (18). hRev1 incorporates
a dCMP efﬁciently opposite lesions including AP sites
(19,20), 8-oxoG, (+)BPDE-dG, ( )BPDE-dG and 1,N
6-
ethenoadenine adducts (21). Together, the aforementioned
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regards to the in vitro lesion bypass spectra of the four
human Y-family DNA polymerases. Yet, with the excep-
tion of a cis-syn TT dimer, it is unclear which human
Y-family enzyme is responsible for the bypass of which
lesion(s) in vivo.
One of the most challenging issues in the ﬁeld of DNA
lesion bypass is to identify the in vivo lesion bypass speci-
ﬁcity of the Y-family DNA polymerases, especially for
those Y-family enzymes that coexist within the same
organism. The knowledge of in vitro lesion bypass efﬁ-
ciency and ﬁdelity of a Y-family DNA polymerase may
shed light on which lesions it bypasses in vivo. However,
the aforementioned in vitro lesion bypass studies have
been performed by different laboratories using different
DNA substrates under different reaction conditions
(22–24). Thus, it is challenging to deduce which human
Y-family enzyme bypasses speciﬁc lesions in vivo.I n
order to exclude these variables, we quantitatively
assessed the AP lesion bypass abilities of the four
human Y-family DNA polymerases using the same
in vitro assay under the same reaction conditions.
Notably, AP lesions are the most common DNA lesions
found in mammalian cells with  10000 spontaneous AP
sites generated in each cell every day (25,26). Herein, we
have employed a recently developed short oligonucleotide
sequencing assay (SOSA) to quantitatively determine the
mutational spectra of these human Y-family enzymes in
the vicinity of this non-coding DNA lesion. Our in vitro
data suggest that hPolZ is likely the Y-family DNA poly-
merase to bypass AP lesions in vivo.
MATERIALS AND METHODS
Materials
Human AP endonuclease and Taq DNA polymerase were
purchased from Trevigen and Invitrogen, respectively.
[g-
32P]ATP was purchased from GE Healthcare Life
Sciences. The oligodeoxynucleotides in Table 1 were
purchased from Integrated DNA Technologies and were
puriﬁed, labeled and annealed as described previously (27).
Protein puriﬁcation
The gene encoding the full-length hPolZ was cloned into
the NdeI and XhoI sites of pET21B to generate a plasmid
pET-21B-hPolZ. The C-terminal His6-tagged hPolZ was
induced and expressed in Escherichia coli BL21(DE3)
Rosetta cells at 16 C. The protein was puriﬁed through
a nickel afﬁnity column, a heparin sepharose column and
a HiTrap SP column.
The gene encoding the N-terminal 420 amino acid
residues of hPoli (hPoli) was inserted into the NcoI
and XhoI sites of pGST-Parallel1 (28) to produce the
plasmid pGST-iota. The N-terminal GST-tag on hPoli
was used to increase the protein-puriﬁcation yield as
hPoli proved to be quite insoluble from cell lysate
(data not shown). The GST-tagged hPoli was expressed
in E. coli BL21(DE3) Rosetta cells at 16 C. The fusion
protein in the cleared lysate was bound to a GSTrap
column. After washing, the fusion protein on the
column was digested with tobacco etch viral protease
(TEV) at 4 C overnight. The free hPoli was then
washed with binding buffer and collected. The pooled
fractions were passed through a DEAE column to
remove any DNA from E. coli. Finally, hPoli was
separated from TEV and other impurities using a
heparin sepharose column.
The gene encoding the truncated fragment (residues
341–829) of hRev1 (hRev1) was cloned into plasmid
pBAD-REV1S (34–829) (29). The protein was induced
with 1% of L-(+)-arabinose and expressed in E. coli
BL21(DE3) at 15 C. The N-terminal His6-tagged
hRev1 was puriﬁed using a nickel afﬁnity column, a
heparin sepharose column and a HiTrap Q column.
The gene encoding the truncated fragment (residues
9–518) of hPolk (hPolk) was inserted into the NcoI
and XhoI sites of the plasmid pHIS-Parallel1 (28) to
create pHIS-hPolkappa-9-518. This plasmid was trans-
formed into E. coli BL21(DE3) Rosetta cells. The
N-terminal His6-tagged hPolk was induced and ex-
pressed at 19 C, and then was puriﬁed using a nickel
afﬁnity column, a heparin sepharose column, a HiTrap
Q column and a Sephacryl 200 gel ﬁltration column.
The concentrations of the puriﬁed recombinant proteins
hPolZ,h Poli,h Rev1 and hPolk were determined
spectrophotometrically at 280nm using calculated
molar extinction coefﬁcients of 70731, 14080, 32430
and 31860M
 1cm
 1, respectively. As both the N- and
C-termini are exposed to solvent and far away from
their active sites (30–32), the His6-tag on either end
should not affect the activities of the hPolZ,h Polk
and hRev1. All experiments were conducted using the
same preparation of each enzyme in order to eliminate
variations between experiments.
Reaction buffer
The reaction buffer H contained 50 mM HEPES (pH 7.5
at 37 C), 5 mM MgCl2, 50 mM NaCl, 5 mM DTT, 10%
glycerol, 0.1 mM EDTA, and 0.1mg ml
 1 bovine serum
albumin (BSA). All reactions were performed at 37 C.
Running start assay
Experiments were performed using a rapid chemical
quench ﬂow apparatus (KinTek) by rapidly mixing a
solution containing 100 nM 50-[
32P] DNA (14-mer/51AP
or 14-mer/51CTL, Table 1) and 100 nM of a human
Table 1. DNA primer and templates
a
Primer
14-mer 50-CGCAGCCGTCCAAC-30
Templates
51AP 30-GCGTCGGCAGGTTGGTTGAGTXG
CAGCTAGGTTACGGCAGGACTCAGGTCC-50
51CTL 30-GCGTCGGCAGGTTGGTTGAGTAGCAGCTA
GGTTACGGCAGGACTCAGGTCC-50
63CTL 30-TTCGTATGGGTAGCGTCGGCAGGTTGGTT
GAGTTGCAGCTAGGTTACGGCAGGACTCA
GGTCC-50
aX designates an AP site.
610 Nucleic Acids Research, 2011,Vol. 39,No. 2Y-family DNA polymerase preincubated in buffer H with
a solution containing all four dNTPs (200 mM each) at
37 C for times ranging from milliseconds to minutes
followed by quenching with 0.37 M EDTA. The nucleo-
tide incorporation pattern was resolved by sequencing gel
analysis.
Short oligonucleotide sequencing assay
SOSA was performed as previously described (33) with the
following modiﬁcations. The DNA substrate (14-mer/
51AP, Table 1) contained the AP site analog tetrahydro-
furan, which was located 22 nucleotides (nt) from the
30-end of the DNA template. For control SOSA, the
DNA substrate (14-mer/63CTL, Table 1) contained a dT
in place of the AP site. The resulting full-length puriﬁed
products were PCR ampliﬁed using the following primers:
16mer_AP_upstream, 50-CACGCAGCCGTCCAAC-30
and 16mer_AP_downstream, 50-GCCCTGGACTCAGG
AC-30. The DNA plasmids containing the ligated
full-length products were sequenced from bacterial
colonies (Genewiz, Inc.). The method is summarized in
Scheme 1.
RESULTS
Our goal was to quantitatively elucidate the relative
abilities of the four human Y-family DNA polymerases
to replicate through an AP site. Previous studies
have indicated that hPolZ (6), hPoli (12–14), hPolk (17)
and hRev1 (18,19) are able to bypass an AP site
in vitro. However, these in vitro studies have not quanti-
tatively evaluated the AP site bypass efﬁciency of the
four human Y-family enzymes. Moreover, there have
been no studies reporting a comprehensive nucleotide in-
corporation proﬁle for these human enzymes that
encompasses nucleotide incorporation events not only
opposite the AP site, but also upstream and downstream
from this non-coding lesion. Such studies are important in
that they will bring us one step closer to possibly
determining which of the human Y-family DNA polymer-
ases preferentially performs AP site bypass in vivo.T o
address these unresolved issues, running start assays
were performed to determine the ability of each human
Y-family enzyme to elongate a 14-mer/51AP substrate
containing an AP site located 22 bases from the 30-end
of the DNA template 51AP (Table 1). The resulting nu-
cleotide incorporation proﬁles were compared to those
obtained with an undamaged DNA substrate 14-mer/
51CTL (Table 1) in order to assess the effect of the AP
site on DNA polymerase activity.
Running start assays
Recombinant hPoli,h Polk and hRev1 were used,
rather than their respective full-length proteins, in the
running start assays because these fragments were able
to be expressed and puriﬁed from E. coli as soluble and
active proteins. Based on the domain structures of these
three enzymes (34) and the published X-ray crystal struc-
tures of these three enzymes (31,32,35), the puriﬁed frag-
ments contain the DNA polymerase core domains.
Importantly, hRev1 has been shown to possess intact
dCMP transferase activity (20) while hPolk and
hPoli are as active as their full-length counterparts
(31,36).
The running start assays for each of the four human
Y-family DNA polymerases were performed under the
same reaction conditions (see Materials and Methods).
These reaction conditions did not deviate signiﬁcantly
from the reaction conditions for individual human
Y-family DNA polymerases used in other laboratories
(10,11,19,37,38), and therefore should not signiﬁcantly
affect the activity of each enzyme. Overall, all four
human DNA polymerases are dissociative in the
Scheme 1. Short oligonucleotide sequencing assay.
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32P]-labeled 14-mer/51AP and
the 50-[
32P]-labeled 14-mer/51CTL DNA substrates based
on intermediate product accumulation patterns (Figure 1).
A general trend was observed in the nucleotide incorpor-
ation proﬁle for each DNA polymerase with the exception
of hRev1 (see below), in that the elongation of the
14-mer/51AP proceeded rapidly until the enzyme encoun-
tered the AP site where analysis of the nucleotide incorp-
oration proﬁle indicated two consecutive strong pause
sites (Figure 1B, D and F). These consecutive pause sites
corresponded to the nucleotide incorporation event
directly opposite the AP site and the subsequent extension
event, suggesting slow turnover at these sites when
compared to the corresponding assays performed with
the 14-mer/51CTL substrate (Figure 1A, C and E).
Nonetheless, the AP site was bypassed relatively efﬁciently
by hPolZ with the full-length product observed at 10s
(Figure 1A and B). The subsequent downstream incorp-
oration was perturbed more signiﬁcantly than the inser-
tion opposite the AP site, indicating that the AP site
modestly affected the elongation of the lesion bypass
product catalyzed by hPolZ (Figure 1). Comparison of
Figures 1D and 1B revealed that hPoli appeared to be
more perturbed by the AP site than hPolZ. There was a
difference in the amount of time required for hPoli to
generate the full-length product between the control
(4 min, Figure 1C) and damaged (7 min, Figure 1D)
DNA substrates. Analogous assays performed with
hPolk showed that this enzyme was also affected by
the AP site as revealed by the elongation patterns of the
damaged (Figure 1F) and the undamaged (Figure 1E)
DNA substrates. Although the nucleotide incorporation
patterns of hPolZ,h Poli and hPolk shared the same
two strong pause sites in the vicinity of the AP site;
hPolk stalled for longer periods of time at these sites
than hPolZ and hPoli, generating the full-length product
30 min after reaction initiation (Figure 1F). Further
analysis of the nucleotide incorporation proﬁles indicated
that hPolZ (Figure 1B) and hPoli (Figure 1D) were rela-
tively more efﬁcient at nucleotide incorporation opposite
the AP site while hPolk (Figure 1F) was more efﬁcient at
catalyzing the subsequent extension step.
Notably, hRev1 was not able to generate the full-
length product with either undamaged (Figure 1G) or
damaged DNA substrates (Figure 1H), even after a 20-h
incubation period at 37 C (data not shown). Additionally,
this enzyme was only able to incorporate  13 nucleotides
on undamaged DNA (Figure 1G), a weak activity that has
Figure 1. Running start assays for human Y-family DNA polymerases: (A) and (B) hPolZ;( C) and (D)h Poli;( E) and (F)h Polk;( G) and
(H)h Rev1. A preincubated solution of a Y-family DNA polymerase (100nM) and 50-[
32P]-labeled DNA (100nM) was mixed with all four dNTPs
(200mM each) for various reaction times before being quenched with 0.37 M EDTA. Reactions using the 14-mer/51CTL substrate are in (A), (C),
(E) and (G) while reactions using the 14-mer/51AP substrate are in (B), (D), (F) and (H).
612 Nucleic Acids Research, 2011,Vol. 39,No. 2been reported previously for hRev1 (39). Notably, hRev1
quickly catalyzed the ﬁrst nucleotide incorporation, which
was opposite template base dG, and stalled signiﬁcantly at
the next nucleotide incorporation opposite template base
dT (Figure 1G and H). This observation was expected as
hRev1 has been found to function as a dCMP transferase
in vitro (19,20). The AP site did not signiﬁcantly inhibit
the primer elongation, although more accumulation of
intermediate 19-mer was observed with the 14-mer/51AP
substrate than with the 14-mer/51CTL substrate,
indicating that the AP site had some effect on the activity
of hRev1 (Figure 1H). Since hRev1 failed to generate
the full-length ‘AP bypass products’ (Figure 1H), we could
not quantitatively analyze its bypass speciﬁcity using
SOSA. The inability to analyze the mutagenic spectrum
for hRev1 should not diminish the veracity of our
results (see Discussion).
Quantitative analysis of the AP bypass efﬁciencies
We further analyzed the results of the running start assays
for hPolZ,h Poli and hPolk by quantitatively
determining their bypass efﬁciencies (AP bypass%). This
was calculated by determining the number of events at a
given time t that the enzyme encountered the AP site
relative to the number of these encounters that resulted
in a lesion bypass event. Thus at reaction time t,a nA P
‘encounter’ was deﬁned as an event where the AP lesion
was located in the enzyme active site, regardless of
whether or not the nucleotide was incorporated. The
total AP bypass events (B) was calculated from the con-
centration of all intermediate products with sizes greater
than or equal to the 22-mer in Figure 1. Therefore, at the
reaction time t, the total AP ‘encounter’ events (E) equaled
the summation of the 21-mer concentration and the total
AP bypass events (B). Finally, we deﬁned the AP bypass%
at reaction time t as the ratio of the bypass events to the
encounter events:
AP bypass%¼ðB=EÞ 100%¼fB=ð½21-mer þBÞg 100%
Figure 2 shows the AP bypass% plotted as a function
of the reaction time for hPolZ,h Poli and hPolk. This
ﬁgure demonstrates that hPolZ required the shortest time
to bypass the AP site while hPolk required the longest
time to traverse the lesion. To quantitatively deﬁne the AP
bypass efﬁciency, we deﬁned t50
bypass as the time required
to bypass 50% of the total AP lesions encountered.
The t50
bypass values, estimated from Figure 2, were 4.6,
112 and 1823s for hPolZ,h Poli and hPolk, respect-
ively (Table 2). Since hRev1 only bypassed the AP lesion
after 184, 360 and 1200 min (Figure 1H) with bypass%
values of 14, 20 and 28%, respectively, we did not plot the
time-dependent AP bypass% for this enzyme. However,
the t50
bypass value of hRev1 was expected to be >1200
min and was estimated to be  2150 min based on these
three time points. Based on the t50
bypass values, hPolZ
possessed the highest AP bypass efﬁciency and bypassed
an AP site 24-, 396- and >28043-fold faster than hPoli,
hPolk and hRev1, respectively. The speciﬁc activity of
the human enzymes to bypass an AP site can be described
as the amount of AP site bypassed (nM) per second, and
were calculated to be 1.1 10
1, 4.5 10
 1, 2.7 10
 2 and
3.9 10
 4nMs
 1 for hPolZ,h Poli,h Polk and
hRev1, respectively.
For comparison, the time (t50) for each enzyme to create
50% of products that extended past a template base dT in
the control template 63CTL, which is at the corresponding
position of the AP site in the template 51AP, was
estimated based on the running start analysis in Figure 1
and is listed in Table 2. The t50
bypass/t50 ratios were
calculated to evaluate the inhibitory effect of the AP site
on DNA synthesis catalyzed by the Y-family DNA poly-
merases (Table 2). The t50
bypass/t50 ratios indicate that the
AP site slowed down hPolk the most (87-fold) while it
had almost no effect on hRev1. The inhibitory effect of
an abasic site on hPolZ (4.6-fold) and hPoli (1.5-fold)
were small but notable.
Quantitative analysis of the mutation spectra of AP bypass
We performed SOSA to determine the precise sequences
of AP lesion bypass products synthesized by each human
Y-family DNA polymerase. Although the t50
bypass values
for each enzyme varied, our assays allowed adequate time
for each enzyme to generate the full-length AP bypass
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Figure 2. Time-dependent AP bypass% during running start assays.
The AP bypass% was plotted as a function of reaction time for
hPolZ (open square), hPoli (closed circle) and hPolk (open circle).
Table 2. The AP bypass efﬁciencies of the human Y-family DNA
polymerases
Enzyme t50
bypass (s)
a t50 (s)
b t50
bypass/t50
hPolZ 4.6 1.0 4.6
hPoli 112 75 1.5
hPolk 1823 21 87
hRev1 129000 129426 1.0
aCalculated as the time required to bypass 50% of the AP sites
(Position 0) in Figure 1.
bCalculated as the time required to bypass 50% of the speciﬁc dT, or
21-mer (Position 0) in Figure 1.
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(33), we modiﬁed the assay (Scheme 1) by increasing the
size of the sequencing window from 8 to 22 nucleotides in
order to increase the number of incorporation events both
upstream (7 nucleotides) and downstream (15 nucleotides)
from the AP site in addition to increasing the reliability of
the statistical analysis.
hPol . To perform SOSA with hPolZ and 14-mer/51AP,
we sequenced 45 colonies and the DNA sequences of the
45 AP lesion bypass products are summarized in
Supplementary Figure S1A. Our results showed that
hPolZ incorporated dAMP (30/45 colonies, 66.7%),
dGMP (9/45 colonies, 20%) or dTMP (2/45 colonies,
4.4%) opposite the AP lesion (Figure 3A). The preference
for dAMP incorporation opposite the AP site was likely
due to the well-established ‘A-rule’ (40). The remaining
events opposite the AP site (4/45 colonies, 8.9%) were
deletion mutations (Figure 3A). These dNMP incorpor-
ation frequencies were comparable to the error%
measured by M13-based reverse mutation assays (41). In
addition, hPolZ generated a signiﬁcant number of substi-
tution, deletion and mixed mutations at positions located
both upstream and downstream from the AP site.
To quantitatively compare mutation frequencies at the
AP site and other template positions, we plotted relative
error% as a function of template positions (Figure 4A).
Each value of relative error% was calculated from the
ratio of total number of mutations (insertions, deletions
and substitutions) divided by the total number of dNMP
incorporations at a speciﬁc template position. To compare
the contributions of different types of mutations to the
value of relative error%, we further calculated the
relative base insertion%, substitution% and deletion%
at each template position. For calculations at the AP
site, since there was no correct dNMP incorporation,
relative base substitution% and insertion% were not
calculated. In order to compare relative deletion% at the
AP site and other template positions, we only presented
relative deletion% at the AP site (Figure 4A).
Interestingly, Figure 4A indicates that dNMP incorpor-
ation was most signiﬁcantly affected at Position 1
(1 nucleotide downstream from AP site) as evidenced by
the highest relative error ( 22.2%) in the sequencing
window. Position 1 was also the strongest pause site in
Figure 1B. Surprisingly, the most error-free incorporation
occurred at the template base position preceding the AP
site (Position -1, Figure 4A). To further examine the
sequence-dependence of the relative error%, we plotted
the relative error% versus the positions of template
bases dTs (Positions -6, -5, -1, 0, 6, 10 and 11;
Figure 5A). Obviously, the relative base deletion%
increased after hPolZ encountered the AP lesion. In
contrast, the relative base substitution% was higher at
positions further away from the AP site and dropped to
0% at Position -1. When opposite template bases dGs
(Positions -7, -4, -2, 1, 4, 8, 9, 14 and 15), the opposite
trends of relative base deletion% and substitution% were
observed with hPolZ (Supplementary Figure S2A). While
the relative base substitution% trend for template bases
dAs (Positions -3, 3, 7 and 12) was similar to the one
observed in Figure 5A, the relative base deletion%
increased only in the vicinity of the AP site
(Supplementary Figure S3A). Notably, there were no
upstream template bases dCs on 51AP. Based on these
template base-dependent analyses, it is apparent that
there is no clear pattern for relative error% during
translesion DNA synthesis catalyzed by hPolZ.
For further evaluation of the effect of the AP site on
upstream and downstream nucleotide incorporations
catalyzed by hPolZ, we performed SOSA using a control
DNA substrate 14-mer/63CTL which has a template
base dT at the corresponding position of the AP site in
14-mer/51AP (Table 1). The control template 63CTL is
12 nucleotides longer than 51AP in order to facilitate
PAGE separation of the full-length products from the
control template which cannot be cleaved by the human
AP endonuclease (Scheme 1). Based on the sequences
gathered (Supplementary Figure S1B), hPolZ
incorporated mostly correct dAMP (85.4%) and occasion-
ally misincorporated dGMP (14.6%) opposite a template
base dT at Position 0 (Figure 3B). However, the mutations
made around Position 0 changed from mostly multi-base
deletions and single-base substitutions of dT and dA in the
presence of the AP site to mostly single-base substitutions
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(black bar).
614 Nucleic Acids Research, 2011,Vol. 39,No. 2of dG and dT in the absence of the AP site
(Supplementary Figures S1A and B). As shown in
Figure 4B, hPolZ created mutations along template
63CTL with an average relative error% of  6.7% at
each template position. This value is similar to the
average error% in Figure 4A. However, the only
observed mutations that occurred with template 63CTL
were base substitutions (Figure 4B and Supplementary
Figure S1B). The relative base substitution error% with
template bases dTs (6–21%) was sequence dependent
(Figure 5A). Similar trends were also observed with
template dAs and dGs (Supplementary Figures 2A and
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Figure 4. Histogram of relative error% as a function of template position. At each position along the DNA template, the relative base insertion%
(white bar), substitution% (striped bar) and deletion% (black bar) are shown to reveal total relative error% and the contribution of each type of
mutation simultaneously. The AP site in 51AP is indicated as ‘AP’ along the X-axis, and the corresponding template base dT in 63CTL is denoted as
‘0’ along the X-axis. For values opposite the AP site, an error was scored only for those nucleotide incorporation events that resulted in a deletion.
AP bypass analyses for hPolZ (A), hPoli (C) and hPolk (E) are shown. DNA synthesis with the control template 63CTL was also analyzed for
hPolZ (B), hPoli (D) and hPolk (F).
Nucleic AcidsResearch, 2011, Vol.39,No. 2 6153A). Overall, the base substitution frequency of hPolZ was
calculated to be 7.5 10
 2 with 14-mer/63CTL (Table 3).
This value was comparable to the error rate of 7.1 10
 2
for combined dT:dG and dA:dC mutations measured by
the M13-based forward mutation assays (42) and to
5.6 10
 2 measured by steady-state kinetic studies (43).
Interestingly, differences in the mutagenic data in
Figure 4A and B suggest that the base deletions and
insertions observed with template 51AP were most likely
caused by the presence of the AP site. Both 2.2% deletion
error frequency at Position -7 and 8.9% insertion-error
frequency at Position -6 (Figure 4A) may also suggest
that hPolZ could detect the presence of the AP site
before the lesion entered its active site.
hDPol . To quantitatively analyze the mutagenic proﬁles
of AP bypass catalyzed by hPoli, we sequenced 45
colonies and the SOSA results are shown in
Supplementary Figure S1C. Interestingly, hPoli lacked
strong preference when incorporating a dNMP directly
opposite the AP site as indicated by the relative nucleotide
incorporation percentages for dAMP (8/45 colonies,
17.8%), dGMP (11/45 colonies, 24.4%), dCMP (1/45
colonies, 2.2%) and dTMP (17/45 colonies, 37.8%) in
addition to the deletion events (8/45 colonies, 17.8%;
Figure 3A). Thus, hPoli did not follow the ‘A-rule’ at
the AP site. These SOSA results were similar to other
published kinetic studies (14,15) with only one difference:
they found that dGMP incorporation opposite an AP site
is slightly more efﬁcient than dTMP. In addition, our
SOSA assay also identiﬁed base deletions opposite the
AP site (Figure 3A). At positions both upstream and
downstream of the AP lesion, hPoli generated a
plethora of base substitution, deletion and insertion mu-
tations that varied from 10 to 80% of the total ﬂux
opposite each template position in the sequencing
window (Figure 4C). There were more mutagenic events
opposite template bases dTs (Figure 5B) than opposite
template bases dAs (Supplementary Figure S3B). As
reported previously (11,44), we also observed the
unusual ability of hPoli to efﬁciently incorporate
dGMP opposite dT at Position -6 where 58% (26/45
colonies) of the total dNMP incorporation events were
dGMP substitution mutations while only 40% involved
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Figure 5. Relative error% as a function of template position from the AP site for hPolZ-( A), hPoli-( B) and hPolk-( C) catalyzed nucleotide
incorporation events opposite template bases dTs. The plots show the relative error% for deletion (open square) and substitution mutations
(open circle) as a function of the template position from the AP site. The relative error% for deletion (closed square) and substitution mutations
(closed circle) as a function of the control template position in 63CTL is also shown for comparison. Only incorporations opposite template base dTs
were analyzed.
616 Nucleic Acids Research, 2011,Vol. 39,No. 2correct dAMP incorporation (Figure 4C). Perhaps most
intriguingly, as hPoli approached the AP site, there was
a sequence-dependent increase in the number of deletion
mutations, and a corresponding sequence-dependent
decrease in deletion mutations as the polymerase pro-
ceeded downstream from the AP site with a maximum
deletion mutation% (26/45 colonies, 58%) observed at
Position 1 (Figures 4C and 5B). This trend was inversely
correlated to the number of substitution mutations
generated by hPoli. Additionally, Positions 0 and 1
were also the strongest pause sites in Figure 1D.
Notably, the results for hPoli indicated an extraordin-
arily high probability of generating frameshift mutations
during AP bypass with a probability of 13% (6/45
colonies) to 58% (26/45 colonies) of the total dNMP in-
corporation events catalyzed within two template bases of
the AP site (Figure 4C).
The effects of the AP site on DNA synthesis catalyzed
by hPoli were more evident when comparing the results
in Supplementary Figure S1C with the results for the
control template 63CTL (Supplementary Figure 1D).
While mostly multi-base deletions were observed in the
immediate area of the AP site, hPoli created mostly
multi-base substitutions with dGMP being the most fre-
quently incorporated incorrect nucleotide on control
template 63CTL. Opposite template bases dTs, the in-
versely correlated, sequence-dependent variation
observed with template 51AP was not observed with
template 63CTL (Figure 5B). The relative error% for
base deletions was lower than base substitutions along
template 63CTL and displayed no sequence bias. Similar
trends are also observed upon comparison of incorpor-
ation events opposite template bases dAs and dGs
(Supplementary Figures 2B and 3B), although the
overall error rate of hPoli opposite dA was relatively
low. While relative error frequencies at speciﬁc positions
on template 63CTL were as high as 76% (Figure 4D),
hPoli synthesized one completely error-free product
out of 44 sequenced products (Supplementary Figure
S1D). Among the 44 dNMP incorporation events
opposite template base dT at Position 0, hPoli made
two base deletions and incorporated dAMP, dGMP,
dTMP and dCMP 23, 19, 0 and 0 times, respectively
(Figure 3B). Again, the data demonstrated that hPoli
formed the base pairs of dG:dT and dA:dT with similar
efﬁciency (11,44). Overall, the base insertion, substitution,
and deletion frequencies with undamaged template 63CTL
were calculated to be 1.2 10
 2, 1.9 10
 1 and
5.1 10
 2, respectively (Table 3). The base substitution
error rate is similar to 1.0 10
 1 measured by steady-state
Table 3. Error rates of the four human Y-family DNA polymerases
Enzyme DNA Event Insertion
Error
a
Insertion
Error Ratio
b
Deletion
Error
c
Deletion
Error Ratio
d
Substitution
Error
e
Substitution
Error Ratio
f
hPolZ 14/63CTL Total
g 0 N/A 0 N/A 7.5 10
 2 N/A
Upstream
h 0 N/A 0 N/A 6.5 10
 2 N/A
Downstream
i 0 N/A 0 N/A 7.9 10
 2 N/A
hPolZ 14/51AP Total
g 4.4 10
 3 – 2.6 10
 2 – 6.4 10
 2 0.85
Upstream
h 0 – 3.5 10
 3 – 5.9 10
 2 0.91
Downstream
i 6.5 10
 3 – 3.6 10
 2 – 6.7 10
 2 0.85
hPoli 14/63CTL Total
g 1.2 10
 2 N/A 5.1 10
 2 N/A 1.9 10
 1 N/A
Upstream
h 6.5 10
 3 N/A 5.8 10
 2 N/A 2.2 10
 1 N/A
Downstream
i 1.5 10
 2 N/A 4.7 10
 2 N/A 1.8 10
 1 N/A
hPoli 14/51AP Total
g 7.0 10
 2 5.8 1.8 10
 1 3.5 1.7 10
 1 0.89
Upstream
h 4.1 10
 2 6.3 1.1 10
 1 1.9 1.8 10
 1 0.82
Downstream
i 8.3 10
 2 5.5 2.2 10
 1 4.7 1.7 10
 1 0.94
hPolk 14/63CTL Total
g 0 N/A 3.9 10
 3 N/A 1.9 10
 2 N/A
Upstream
h 0 N/A 0 N/A 2.0 10
 2 N/A
Downstream
i 0 N/A 5.7 10
 3 N/A 1.8 10
 2 N/A
hPolk 14/51AP Total
g 3.2 10
 3 – 5.4 10
 2 14 6.3 10
 2 3.3
Upstream
h 0 – 1.5 10
 2 – 3.1 10
 2 1.6
Downstream
i 4.8 10
 3 – 7.1 10
 2 12 7.9 10
 2 4.4
‘–’ means the ratio cannot be calculated because the denominator is 0. ‘N/A’ means not applicable.
aCalculated as (base insertions)/[(sample size) (number of bases in a speciﬁc event)].
bCalculated as {(base insertions)/[(sample size) (number of bases in a speciﬁc event)]}51AP/{(base insertions)/[(sample size) (number of bases in
a speciﬁc event)]}63CTL.
cCalculated as (base deletions)/[(sample size) (number of bases in a speciﬁc event)].
dCalculated as {(base deletions)/[(sample size) (number of bases in a speciﬁc event)]}51AP/{(base deletions)/[(sample size) (number of bases in a
speciﬁc event)]}63CTL.
eCalculated as (base substitutions)/[(number of samples) (number of bases in a speciﬁc event)].
fCalculated as {(base substitutions)/[(sample size) (number of bases in a speciﬁc event)]}51AP/{(base insertion)/[(sample size) (number of bases
in a speciﬁc event)]}63CTL.
gTotal events include all dNMP incorporation events during DNA synthesis of full-length products except those that occurred at Position 0 in
Figure 4.
hUpstream events include all dNMP incorporation events during DNA synthesis of full-length products that occurred before an enzyme encountered
Position 0 or ‘AP’ in Figure 4.
iDownstream events include all dNMP incorporation events during DNA synthesis of full-length products that occurred after an enzyme traversed
Position 0 or ‘AP’ in Figure 4.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 617kinetic studies (45). When comparing the relative error%
along the templates 63CTL (Figure 4D) and 51AP
(Figure 4C), the relative error% for hPoli in the
presence of an AP site increased at almost every
template position.
hDPol . We sequenced 55 AP lesion bypass products
formed by hPolk and the SOSA results are shown in
Supplementary Figure S1E. Opposite the AP lesion
(Figure 3A), 60% (33/55 colonies) of the nucleotide in-
corporation events were dAMP incorporations, 8.5% (3/
55 colonies) were dTMP incorporations, 34.5% (19/55
colonies) were no incorporations and 0% (0/55 colonies)
were dCMP and dGMP incorporations, suggesting that
hPolk, like hPolZ, followed the ‘A-rule’ to select an
incoming dNMP opposite the AP site. This conclusion is
consistent with previously published results derived from
single dNMP incorporation assays (17). The strong pause
sites observed in Figure 1F were the same positions that
created the most deletion mutations shown in Figure 4E.
Notably, there were a signiﬁcantly higher number of sub-
stitution and frameshift mutations at template positions
downstream from the AP lesion (Figure 4E), which
was not observed with hPolZ (Figure 4A) and hPoli
(Figure 4C). When following the dTs along template
51AP, the inversely correlated relative base substitution%
and deletion% observed with hPoli was also observed
with hPolk (Figure 5C). Opposite template bases dGs
and dAs, hPoli followed similar patterns of relative
base substitution% and deletion% (Supplementary
Figures S2C and 3C).
With undamaged 14-mer/63CTL (Table 1), our SOSA
data (Supplementary Figure S1F) indicated that hPolk
made signiﬁcantly less errors with control 14-mer/51CTL
(Figure 4F) than with damaged 14-mer/51AP (Figure 4E).
Although hPolk created multi-base deletions in the im-
mediate vicinity of the AP site, mostly single-base substi-
tutions were observed when the AP site was replaced
with base dT (Supplementary Figure S1F). For the
61 sequenced full-length products in Supplementary
Figure S1F, the base insertion, substitution and deletion
error rates were calculated to be 0, 1.9 10
 2 and
3.9 10
 3, respectively (Table 3), and the base substitu-
tion error rate was similar to 1.4 10
 2 measured by
steady-state kinetic studies (46). Among the 61 dNMP
incorporation events opposite dT at Position 0, hPolk
only misincorporated one dGMP and one dTMP and did
not make any other mutations (Figure 3B). Opposite
template bases dTs in 63CTL, there were no base deletions
and few base substitutions (Figure 5C). Similar trends
were also observed when hPolk incorporated dNMPs
opposite template bases dGs and dAs (Supplementary
Figures S2C and 3C). When comparing Figure 4E
and F, it was clear that the relative error% at each
template position increased signiﬁcantly in the presence
of an AP site.
All Y-family human enzymes. Within the distinct charac-
teristic ﬁdelity of each of the three human Y-family
enzymes, there were mutational hotspots observed for
both templates 51AP and 63CTL. All three DNA
polymerases created a substantial amount of mutations
at Positions 0 and 1 in the presence of the AP site with
deletion mutations having the highest frequency
(Figure 4). Furthermore, these positions created the
strongest pause sites during running start analysis
(Figure 1). There were also common distal positions down-
stream from the AP site (Positions 10 and 11) where these
enzymes created mostly base substitutions. At Positions 10
and 11, the most frequent mutation was a base substitution
to either dT or dG for all enzymes (Supplementary Figure
S1). Similarly, both hPolZ and hPoli displayed high
frequencies of mutations at Positions -6 and -5 on both
templates 51AP and 63CTL. At these positions where
slight enzyme pauses occurred during running start
analysis (Figure 1), these two enzymes created mostly a
base substitution to dG (Supplementary Figure S1).
Thus, the slight pause sites were directly correlated to mu-
tational hotspots observed by SOSA. Notably, while
downstream nucleotide incorporation events were not sig-
niﬁcantly affected, the observation of increased deletion
and insertion mutations upstream from the AP site may
be suggestive of a mechanism by which hPolZ was affected
by the AP site several nucleotides prior to encountering the
lesion in its active site (Figure 4A). This upstream AP effect
was also observed with both hPoli and hPolk (Figure
4). In addition, the AP lesion affected downstream nucleo-
tide incorporation catalyzed by hPoli and hPolk
(Figure 4).
DISCUSSION
A mammalian genome is estimated to undergo  100000
modiﬁcations per day (47). It is obvious that the four
human Y-family DNA polymerases have to bypass differ-
ent types of DNA lesions efﬁciently in order to rescue and
facilitate DNA replication. While S. solfataricus Dpo4 has
served as an excellent model for characterizing the
Y-family, it has become apparent that DNA polymerases
even within the same family possess structural and func-
tional attributes that render them fundamentally different
from one another (48). Thus, it is extremely likely that the
Y-family DNA polymerases, especially those from the
same organism, possess distinct lesion bypass speciﬁcities
in vivo. We hypothesized that one Y-family DNA poly-
merase may play a dominant role on the insertion or ex-
tension bypass of a speciﬁc lesion while other DNA
polymerases may play a secondary role. In order to
maintain genetic stability, we further hypothesized that
the in vivo bypass of a widespread lesion such as the AP
site requires a relatively efﬁcient and faithful Y-family
DNA polymerase that causes few frameshift mutations.
In this article, we quantitatively analyzed all four human
Y-family enzymes for their abilities to perform AP bypass.
The resulting analyses are discussed herein.
Human Rev1 is not the DNA polymerase to bypass
AP lesions in vivo
For the following reasons, Rev1 does not appear to play
an important DNA polymerase role in AP lesion bypass
in vivo. First, previous studies have shown hRev1 to
618 Nucleic Acids Research, 2011,Vol. 39,No. 2function as a dCMP transferase that uses a novel mech-
anism involving the side chain of Arg357 in the N-digit
domain that speciﬁcally interacts with the base of dCTP
through hydrogen bonds to direct dCMP incorporation
(32). This property is supported by our recently pub-
lished kinetic studies on hRev1 which preferentially
incorporated dCMP opposite all four possible template
bases (49). This low ﬁdelity of hRev1 could severely com-
promise genomic stability. Second, among the four
human Y-family DNA polymerases, hRev1 possesses
the lowest AP bypass efﬁciency (see Results) and may
not be able to timely bypass numerous AP sites
generated per cell per day (25,26). Third, due to the
ability of Rev1 to speciﬁcally interact with DNA poly-
merases Z, k and i, but not with other DNA polymerases
such as b orm (50–52) coupled with the observation that
Rev1 will switch its interaction partner based on the
relative concentrations of the competing Y-family DNA
polymerases (50), it has recently been hypothesized that
Rev1 may have an important role in mediating the DNA
polymerase switching process by serving as a protein
scaffold. Finally, additional evidence for the scaffold
role of Rev1 were provided by demonstrating that
Rev1 is required for DNA-damage induced mutagenesis
in yeast, but its dCMP transferase activity is not required
for AP site bypass in vivo (53).
hPolg possesses the highest AP bypass efﬁciency in vitro
Using similar running start analysis performed previously
for Dpo4 (54), our data demonstrated that hPolZ,h Poli
and hPolk were able to bypass a site-speciﬁcally placed
AP site and subsequently generate the full-length bypass
product. Based on the t50
bypass values for hPolZ,h Poli
and hPolk estimated in Figure 2, hPolZ possessed the
highest AP bypass efﬁciency and bypassed an AP site 24-
and 396-fold faster than hPoli and hPolk, respectively.
Relative to the control DNA substrate, the presence of an
AP site had only a slight inhibitory effect on the polymer-
ase activity of hPolZ and hPoli but signiﬁcantly slowed
the hPolk-catalyzed DNA synthesis. Moreover, further
analysis of the nucleotide incorporation proﬁle indicated
that hPolZ and hPoli were relatively more efﬁcient at
nucleotide incorporation opposite the AP site while
hPolk was more efﬁcient at catalyzing the subsequent
extension step. Such observations agree with previous
reports that Polk has a unique ability to extend mispaired
and aberrant primer termini (16,55). This superior exten-
sion ability can be explained by the presence of a unique
N-terminal extension of the palm domain, which helps
stabilize the Polk DNA complex at the primer–terminus
junction (31).
hPolg has a lower mutagenic potential than h"Poli and
h"Poli during AP bypass
Analysis of the mutation spectra of AP bypass observed
via SOSA revealed several general trends: (i) opposite the
AP site, all three enzymes made frameshift mutations with
the following order of deletion frequency: hPolZ< hPoli
< hPolk (Figure 3A); (ii) at template positions other
than Position 0 (Table 3), all three human Y-family
enzymes had higher deletion and insertion frequencies
with the damaged template 51AP than with the control
template 63CTL (Figure 4); (iii) the base deletion and in-
sertion frequencies of each of the three human Y-family
enzymes increased signiﬁcantly after the enzyme encoun-
tered the AP site (Table 3); (iv) with both templates 51AP
and 63CTL, hPoli made more insertion, deletion
and substitution mutations than hPolZ and hPolk
(Table 3); and (v) hPolZ was the least likely human
Y-family polymerase to generate frameshift mutations in
the vicinity of the AP site.
Sensing of a lesion by DNA polymerases. Figure 3A shows
that hPolZ preferentially incorporated dAMP opposite
the AP site, a preference that has been observed previously
in some mammalian cells lines (48,50,51). Additionally,
while downstream nucleotide incorporation events were
not signiﬁcantly affected, the observation of increased
deletion and insertion mutations upstream from the AP
site (Figure 4A) may be suggestive of a mechanism by
which hPolZ is affected by the AP site several bases
prior to encountering the lesion within its active site.
This observation was also made for AP translesion
DNA synthesis catalyzed by both hPoli (Figure 4C)
and hPolk (Figure 4E). This ability to sense DNA
lesions has been reported previously for Pyrococcus
furiosus (Pfu) DNA polymerase, which has been shown
to sense uracil in a DNA template at least four bases
upstream from the lesion (56). In addition, S. solfataricus
DNA polymerase B1 has been shown to be affected by
uracil and hypoxanthine four bases upstream of these
lesions, although the inhibitory effect is not as substantial
as that reported for Pfu DNA polymerase (56,57). How a
polymerase senses a DNA lesion is unclear. Based on
crystal structures of eukaryotic Y-family DNA polymer-
ases (32,58–60), the 50 single-strand portion of the DNA
template from the primer and template junction is
threaded through the interface between the ﬁnger
domain and polymerase-associated domain (PAD), or
little ﬁnger domain, and interacts with amino acid
residues in the interface. The presence of a damaged
template base may affect these interactions, facilitating
the polymerase to sense the upstream lesion and make
more mutations.
Potential deletion mechanism of hPol . The results for
hPoli indicated an extraordinarily high probability of
generating frameshift mutations during AP bypass
(Figure 4C). Interestingly, a recent crystal structure of
hPoli with an AP-containing DNA substrate indicates
that the protrusion of the AP site would be sterically
forbidden in hPoli by the presence of Lys60 and Glu97
of the ﬁnger domain and Ser307 of the PAD (61). Thus, it
is possible that hPoli utilizes a different AP site bypass
mechanism, such as a primer misalignment, to generate
the large number of frameshift mutations observed
within the sequencing window. In addition, the inactiva-
tion of hPolZ, i.e. XPV cell lines, is known to have the
phenotype of hypermutability after exposure to
DNA-damaging conditions (62). The hypermutability
that was observed for hPoli (Figure 4C), which was
Nucleic AcidsResearch, 2011, Vol.39,No. 2 619the second most efﬁcient enzyme to bypass an AP site
in vitro, suggests that hPoli may substitute for the defect-
ive hPolZ during the bypass of AP sites in the XPV cell
lines (63).
Impact of an AP lesion on hDPol . hPolk, which is
shown to generate -1 deletions even on undamaged
DNA (64,65), was intermediate to hPolZ and hPoli,
generating a moderate number of base deletion mutations
immediately downstream from the AP site in a manner
similar to that reported for its Y-family homolog Dpo4
(55). Furthermore, the embedded AP site affected the
accuracy of dNMP incorporation catalyzed by hPolk
for at least 15 bases downstream from the AP site
(Figure 4E), which was similar to the pre-steady state
kinetic data reported for Dpo4 (54). Together, these
data indicate that the mutagenic effects of an AP site on
DNA synthesis catalyzed by Polk and Dpo4 are similar.
Potential role of the little ﬁnger domain on a Y-family
enzyme’s lesion bypass abilities. The abovementioned dif-
ferences in the AP bypass efﬁciency and mutagenic fre-
quency among human Y-family DNA polymerases are a
fundamental function of the ability of the enzymes to in-
corporate a dNMP directly opposite the AP site. This
ability has been shown to be inﬂuenced by the PAD or
little ﬁnger domain, which can modulate the activity of the
enzyme by modifying the relative position of the DNA
within the polymerase active site (66,67). As a proof of
principle, the bypass speciﬁcity has been shown to be sig-
niﬁcantly inﬂuenced by the little ﬁnger domain in a study
that swapped this domain in two Y-family polymerases
and observed a switch of the bypass speciﬁcities (68).
Thus, our data collectively demonstrate the functional dif-
ferences between DNA polymerases from the same phylo-
genetic family.
In summary, our study serves as an initial attempt to
understand the precise mutagenic proﬁle of each of the
four human Y-family polymerases in response to an AP
site. The data presented suggest that the most likely
Y-family polymerase to bypass an AP site in vivo is
hPolZ, due to (i) the extremely high frameshift potential
of hPoli, (ii) the higher potential of hPolk to create
frameshift mutations as opposed to directly incorporating
dNMP at the AP site, (iii) the weak polymerase activity
observed opposite the AP site by hRev1 coupled with its
reported preference to function as a scaffolding protein
and (iv) the low frameshift potential and extremely high
AP bypass efﬁciency of hPolZ. Future studies with a
variety of different DNA lesions are forthcoming, and
will certainly provide a plethora of useful information re-
garding lesion bypass speciﬁcity.
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